The Data Core provides a central resource to the ADCS consortium for expertise in the design, management, quality control and analysis of Alzheimer's disease clinical trials. The biostatistical responsibilities of the Data Core include: collaborating on the experimental design of each protocol; developing and generating the randomization sequences for each trial; performing preliminary and final statistical analysis on trial results; the preparation of reports and publication; and developing new statistical methodology. All ADCS clinical trial data is managed through the Data Core. Every aspect of the data collection process, including forms design and printing, maintaining centralized patient files, and generating special purpose and routine statistical reports on accumulating data, is coordinated through the data management operation of the Data Core. The Data Core computing environment consists of approximately 50 workstations connected in a client-server architecture, using a TCP/IP local area network (LAN) with 4 servers (web, file, data, and mail). The network is secured behind a firewall. Data management is conducted through the Oracle relational database management system. The quality assurance program of the Data Core is extensive. At its center is the clinical and computerized monitoring of the data, but it extends to cover training, study initiation, sub-contractor liaison, supply procurement, document (training manuals, manuals of operation, newsletters, etc.) and instrument development. The Data Core coordinates a clinical monitoring program through which all ADCS data forms are reviewed on-site by highly trained monitors. Computerized edit checking is done both at the time of entry and longitudinally. The Data Core maintains public and private web sites in support of ADCS activities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AG010483-12
Application #
6653987
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-09-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Rockenstein, Edward; Ostroff, Gary; Dikengil, Fusun et al. (2018) Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. J Neurosci 38:1000-1014
Edmonds, Emily C; Ard, M Colin; Edland, Steven D et al. (2018) Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y) 4:11-18
Chen, Yun-Fei; Ni, Xiao; Fleisher, Adam S et al. (2018) A simulation study comparing slope model with mixed-model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease. Alzheimers Dement (N Y) 4:46-53
Jacobs, Diane M; Ard, M Colin; Salmon, David P et al. (2017) Potential implications of practice effects in Alzheimer's disease prevention trials. Alzheimers Dement (N Y) 3:531-535
Moussa, Charbel; Hebron, Michaeline; Huang, Xu et al. (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation 14:1
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
El-Agnaf, Omar; Overk, Cassia; Rockenstein, Edward et al. (2017) Differential effects of immunotherapy with antibodies targeting ?-synuclein oligomers and fibrils in a transgenic model of synucleinopathy. Neurobiol Dis 104:85-96
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Tarrant, Sarah D; Bardach, Shoshana H; Bates, Kendra et al. (2017) The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease. Alzheimer Dis Assoc Disord 31:141-145
Kennedy, Richard E; Cutter, Gary R; Wang, Guoqiao et al. (2017) Challenging Assumptions About African American Participation in Alzheimer Disease Trials. Am J Geriatr Psychiatry 25:1150-1159

Showing the most recent 10 out of 294 publications